Naud, Paulo S <br/><br/>
Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine: final analysis of a long-term follow-up study up to 9.4 years post-vaccination.  [electronic resource] 

 -  Human vaccines & immunotherapeutics  2014 
 - 2147-62 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>2164-554X 
<br/><br/><label>Standard No.: </label>10.4161/hv.29532  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antibodies, Neutralizing--blood<br/>Antibodies, Viral--blood<br/>Brazil<br/>DNA, Viral--analysis<br/>Drug-Related Side Effects and Adverse Reactions--epidemiology<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Follow-Up Studies<br/>Histocytochemistry<br/>Human papillomavirus 16--immunology<br/>Human papillomavirus 18--immunology<br/>Humans<br/>Neutralization Tests<br/>Papillomavirus Infections--prevention & control<br/>Papillomavirus Vaccines--administration & dosage<br/>Treatment Outcome<br/>Uterine Cervical Neoplasms--prevention & control<br/>Vaginal Smears<br/>Young Adult